Are randomised trials obsolete or more important than ever? - European Medical Journal

Are randomised trials obsolete or more important than ever?

Oncology
At the 14th St. Gallen International Breast Cancer Conference (SG-BCC) 2015, Dr Clifford Hudis (Memorial Sloan Kettering Cancer Center, New York, NY) Dr Clifford Hudis (Memorial Sloan Kettering Cancer Center, New York, NY) discusses the use of electronic medical records as a source of data that could potentially transform healthcare. CancerLinQ is one initiative that is aiming to aggregate and analyse data collected from patients.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now